Effect of sildenafil citrate on viability of flaps: An experimental study in rats

Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery

Volumn 39, Issue 4, 2005, Pages 204-208

  Ayyildiz, Ali ^a,b   Uysal, Afşin ^a   Koçer, Uǧur ^a   Karaaslan, Önder ^a   Huri, Emre ^a   Germiyanoǧlu, Cankon ^a   Çaydere, Muzaffer ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Keklikpinari Mah 55 ^*  (Turkey)

Author keywords

Flap viability; Sildenafil citrate

Indexed keywords

SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; ISCHEMIA; NONHUMAN; PATHOPHYSIOLOGY; RAT; SKIN FLAP SURVIVAL; SKIN NECROSIS; TREATMENT OUTCOME;

ANIMALS; FEMALE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; RATS; RATS, WISTAR; SURGICAL FLAPS; TISSUE SURVIVAL; VASODILATOR AGENTS;

EID: 24644520994     PISSN: 02844311     EISSN: None     Source Type: Journal    
DOI: 10.1080/02844310510006268     Document Type: Article

References (23)

1. Ergun H, Cilingir MG, Apaydin I, et al. The effect of dipyrone on survival of skin flaps. Scand J Plast Reconstr Surg Hand Surg 2001;35:19-22.
2. Tellioglu AT, Uras KA, Yilmaz T, et al. The effect of carnitine on random-pattern flap survival in rats. Plast Reconstr Surg 2001;108:959-62.
3. Davis RE, Wachholz JH, Jassir D, et al. Comparison of topical anti-ischemic agents in the salvage of failing random pattern skin flaps in rats. Arch Facial Plast Surg 1999;1:27-32.
4. Kerrigan CL, Daniel RK. Pharmacologic treatment of the failing skin flap. Plast Reconstr Surg 1982;70:541-9.
5. Huemer GM, Wechselberger G, Otto-Schoeller A, et al. Improved dorsal random-pattern skin flap survival in rats with a topically applied combination of novamide and nicoboxil. Plast Reconstr Surg 2003;111:1207-11.
6. Brock G. Sildenafil citrate (Viagra®). Drugs Today 2000;36:125-34.
7. Corbin JD, Francis SH. Cyclis GMP phosphodiesterase-5: target of sildenafil. J Biol Chem 1999;274:13729-32.
8. Li Z, Xi X, Gu M, et al. A stimulatory role for cGMP-dependent protein kinase in platelet activation. Cell 2003;112:77-86.
9. McFarlane RM, De Young G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg 1965;35:177-82.
10. Nichter LS, Sobieski MW, Edgerton MT. Efficacy of topical nitroglycerine for random pattern skin-flap salvage. Plast Reconstr Surg 1985;75:847-52.
11. Pratt MF. Edmund Prince Fowler thesis. Evaluation of random skin flap survival in a porcine model. Laryngoscope 1996;106:700-12.
12. Pratt MF, Williams PB. Pentoxifylline and acetylsalicylic acid in a pig random skin flap model. J Otolaryngol 1996;25:393-8.
13. Rohrich RJ, Cherry GW, Spira M. Enhancement of skin-flap survival using nitroglycerine ointment. Plast Reconstr Surg 1984;73:943-8.
14. Waters LM, Pearl RM, Macaulay RM. A comparative analysis of the ability of five classes of pharmacological agents to augment skin flap survival in various models and species: an attempt to standardize skin flap research. Ann Plast Surg 1989;23:117-22.
15. Ueda K, Harii K. Comparative study of topical vasodilating solutions. Scand J Plast Reconstr Surg Hand Surg 2003;37:201-7.
16. Hanley SP, Bevan J, Cockbill SR, et al. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet 1981;1:969-71.
17. Li X, Cooley BC. Effect of anticoagulation and inhibition of platelet aggregation on arterial versus venous microvascular thrombosis. Ann Plast Surg 1995;35:165-9.
18. Shalom A, Herbert M, Westreich M. Effect of aspirin on random pattern flap survival in rats. Eur J Plast Surg 2000;23:21-4.
19. Shalom A, Westreich M. Effect of high dose and low dose aspirin on survival of random pattern flaps in rats. Scand J Plast Reconstr Surg Hand Surg 2001;35:117-21.
20. Schulze-Neick I, Hartenstein P, Li J, et al. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 2003;108 (suppl II):167-73.
21. Cremers B, Scheler M, Maack C, et al. Effects of sildenafil (Viagra) on human myocardial contractility, in vitro arrhythmias, and tension of internal mammaria arteries and saphenous veins. J Cardiovasc Pharmacol 2003;41:734-43.
22. Mittleman MA, Glasser DB, Orazem J. Clinical trials of sildenafil citrate (Viagra) demonstrate no increase in risk of myocardial infarction and cardiovascular death compared with placebo. Int J Clin Pract 2003;57:597-600.
23. Serhatlioglu S, Kiris A, Kocakoc E, et al. Evaluation of the effects of sildenafil citrate (Viagra) on canine renal artery, carotid and aortic blood flow with the aid of color Doppler sonography. Urol Int 2003;71:103-7.